38 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2028. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
24
Ending by 2030
Dec 2028
Next term end
10
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2030 · High confidence
Also notable
Ends Dec 2028 · Medium confidence
Also notable
Ends Jun 2032 · Medium confidence
Also notable
Ends Mar 2037 · High confidence
Also notable
Ends Aug 2037 · High confidence
Also notable
Ends Jan 2037 · High confidence
Also notable
Ends Jan 2030 · Medium confidence
Also notable
Ends no later than May 2030 · Low confidence
Hyaluronic Acid-Based Gels Including Lidocaine
US 8,450,475
The most cited patent in this portfolio, cited by 125 later US patents, top 5% of utility patents granted in 2013 in our data. Protection runs to 2030.
Polysaccharide Gel Formulation Having Increased Longevity
US 8,394,782
Cited by 122 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Dermal Filler Compositions
US 11,083,684
Cited by 17 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2032.
Thread Insertion Devices
US 10,595,977
Cited by 8 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037.
Thread Insertion Devices
US 10,820,900
Cited by 9 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2037.
Thread Insertion Devices
US 10,258,447
Granted 2019. Computed term ends 2037.
Stable Hydrogel Compositions Including Additives
US 9,114,188
The largest patent family in this portfolio, 13 related applications, renewed at every maintenance window due so far. Protection runs to 2030. A terminal disclaimer caps this term to an earlier patent's.
Fluid Compositions for Improving Skin Conditions
US 8,921,338
Granted 2014 and renewed at every maintenance window due so far. Protection runs to 2030. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Jan 28, 2027
- 2 fees due Feb 25 to 27, 2027 · next Feb 25
- 2 fees due Apr 6 to 22, 2027 · next Apr 6
- 1 fee due May 26, 2027The maintenance fee for Hyaluronic Acid-Based Gels Including Lidocaine (US 10,485,896) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Jul 19, 2027The maintenance fee for Hyaluronic Acid-Based Gels Including Lidocaine (US 9,238,013) comes due Jul 19, 2027. Unpaid by Jan 19, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Thread Insertion Devices (US 10,595,977) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Dermal Filler Compositions Including Antioxidants (US 10,624,988) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
- 1 fee due Nov 10, 2027The maintenance fee for Heat Stable Hyaluronic Acid Compositions for Dermatological Use (US 9,333,160) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
What they patent
The largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Hyaluronic Acid-Based Gels Including Lidocaine | 13 in force | to Dec 2030 |
| Dermal Filler Compositions Including Antioxidants | 10 in force | to Aug 2032 |
| Stable Hydrogel Compositions Including Additives | 6 in force | to Mar 2030 |
| Thread Insertion Devices (2017) | 2 in force | to Mar 2037 |
| Thread Insertion Devices (2017) | 2 in force | to Mar 2037 |
| Fluid Compositions for Improving Skin Conditions | 1 in force | to May 2030 |
| Polysaccharide Gel Formulation Having Increased Longevity | 1 in force | to Dec 2028 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,394,782 | Polysaccharide Gel Formulation Having Increased Longevity In force · Medium confidence | In force | Medium confidence | |
| US 8,822,676 | Hyaluronic Acid-Based Gels Including Lidocaine In force · High confidence | In force | High confidence | |
| US 9,089,517 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence | |
| US 9,089,518 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence | |
| US 9,089,519 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence | |
| US 9,238,013 | Hyaluronic Acid-Based Gels Including Lidocaine In force · High confidence | In force | High confidence | |
| US 10,328,180 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Low confidence | In force | Low confidence | |
| US 10,391,202 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence | |
| US 10,485,896 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence | |
| US 11,020,512 | Hyaluronic Acid-Based Gels Including Lidocaine In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 38: 9 patents ended · 4 applications pending · 24 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.